XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.18

-0.4%

12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (8091)	12/20/1998 2:36:00 AM
From: Tharos	Read Replies (2) of 17367

Well, I do look for sepsis control and antibiotic synergy to be two potential markets for Neuprex. Even more exciting is the discovery that hu1124 has a positive effect on T-cells. The more I study, the more I become convinced that BPI plays a key role in the body and has potential to be used in AIDS and cancer treatments.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next